Información de la revista
Vol. 52. Núm. 6.
Páginas 501-506 (Junio 2000)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 52. Núm. 6.
Páginas 501-506 (Junio 2000)
Acceso a texto completo
Correlación entre carga viral elevada y concentraciones de TNF-α y cICAM-1 en el plasma de niños infectados por el VIH-1
Relationship between high plasma viral load and levels of tnf-a and cicam-1 in vertically hiv-1 infected children
Visitas
5712
S. Resinoa, J.L. Jiméneza, J.M. Bellóna, D. Gurbindob, M.A. Muñoz-Fernándeza,
Autor para correspondencia
Mmunoz@cbm.uam.es

Correspondencia: Hospital General Universitario Gregorio Marañón. División de Inmunología. Dr. Esquerdo, 46. 28007 Madrid
a Secciones de Inmunología Hospital General Universitario Gregorio Marañón. Madrid.
b Inmuno-Pediatría. Hospital General Universitario Gregorio Marañón. Madrid.
Este artículo ha recibido
Información del artículo
Objetivo

Analizar si existe relación entre los valores plasmáticos del factor de necrosis tumoral (TNF-α) y la molécula de adhesión intercelular circulante tipo 1 (cICAM-1) con valores de carga viral plasmática (CV) en niños infectados verticalmente por el VIH.

Pacientes y métodos

Estudiamos 44 niños VIH-1 y un grupo control de 38 niños no infectados por el VIH-1. Las subpoblaciones celulares se realizaron por citometría de flujo, las concentraciones de TNF-α y cICAM-1 se cuantificaron por técnicas de enzimoinmunoanálisis y la CV se cuantificó mediante un análisis molecular estándar comercial.

Resultados

Los niños infectados por el VIH-1 presentaron valores significativamente más altos de TNF-α y cICAM-1 que los niños del grupo control. Dividimos a los niños VIH-1 según los valores de CV. Los niños VIH-1 con CV mayor de 50.000 copias/ml produjeron más TNF-α (12,83; IC del 95%: 24,71-0,95 pg/ml) y cICAM-1 (248,94; IC del 95%: 419,01-78,84 ng/ml) que los niños VIH-1 con CV inferior a 50.000 copias/ml, de tal forma que se producía un incremento de 6,57 pg/ml de TNF-α y de 119,97 ng/ml de cICAM-1 por cada log10 de CV.

Conclusiones

Nuestros datos indican que a medida que en el plasma de los niños VIH-1 se incrementan los valores de CV también se incrementan los valores de TNF-α y cICAM-1.

Palabras clave:
VIH
Niños
Carga viral
TNF-α
cICAM-1
Objective

To assess the relationship among plasma TNF-α and cICAM-1 levels and plasma viral load (VL) in HIV-infected children and to compare these values with those of healthy non-HIV infected children.

Patients and methods

We studied 44 HIV-infected children and 38 non-HIV-infected children. The VL was quantified using standard molecular assay. CD4 and CD8 lymphocyte subpopulations were determined by flow cytometry. TNF-α and cICAM-1 were quantified using commercially available specific enzyme-linked immunosorbent assay (ELISA).

Results

Levels of TNF-α and cICAM-1 were higher in HIV-infect-ed children than in non-HIV infected children. HIV-infected children with VL > 50000 copies/ml had higher levels of TNF-α (12.83; 95% CI: 24.71 to 0.95 pg/ml) and cICAM-1 (248.94; 95% CI: 419.01 to 78.84 ng/ml) than HIV-infected children with VL < 50000 copies/ml. Interestingly, we found an increase of 6.57 pg/ml of TNF-α and 119.97 ng/ml of cICAM-1 levels for each log10 of VL.

conclusions

HIV-infected children had higher levels of TNF-α and cICAM-1 than healthy controls. Our data indicate a positive correlation among plasma TNF-a and cICAM-1 and VL levels.

Key words:
HIV
Children
Viral load
TNF-a
cICAM-1
El Texto completo está disponible en PDF
Bibliografía
[1.]
G. Pantaleo, C. Graziosi, J.F. Demarest, L. Butini, M. Montroni, C.H. Fox, et al.
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.
Nature, 362 (1993), pp. 355-358
[2.]
M. Clerici, N.I. Stocks, R.A. Zajac, R.N. Boswell, D.R. Lucey, C.S. Via, et al.
Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virusseropositive. Independence of CD4+ cell numbers and clinical stating.
J Clin Invest, 84 (1989), pp. 1892-1899
[3.]
Z. Liu, W.G. Cumberland, L.E. Hultin, H.E. Prince, R. Detels, J.V. Giorgi.
Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
J Acquir Immune Defic Syndr Hum Retrovirol, 16 (1997), pp. 83-92
[4.]
P. Aukrust, N.B. Liabakk, F. Muller, E. Lien, T. Espevik, S.S. Froland.
Serum level of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection-correlations to clinical, immunologic, and virologic parameters.
J Infect Dis, 169 (1994), pp. 420-424
[5.]
D. Hamann, P.A. Baars, M.H. Rep, B. Hooibrink, S.R. Kerkhof-Garde, M.R. Klein, et al.
Phenotypic and functional separation of memory and effector human CD8+ T cells.
J Exp Med, 186 (1997), pp. 1407-1418
[6.]
D. Israel-Biet, J. Cadranel, K. Beldjord, J.M. Andrieu, A. Jeffrey, P. Even.
Tumor necrosis factor production in HIV-seropositive subjects. Relationships with lung opportunistic infections and HIV expression in alveolar macrophages.
J Immunol, 147 (1991), pp. 490-497
[7.]
A.S. Lau, B.R. Williams.
The role of interferon and tumor necrosis factor in the pathogenesis of AIDS.
J Exp Pathol, 5 (1990), pp. 111-122
[8.]
J.F. Salazar-González, O. Martínez-Maza, N. Aziz, J.A. Kolberg, T. Yeghiazarian, L.P. Shen, et al.
Relationship of plasma HIVRNA levels and levels of TNF-alpha and immune activation products in HIVinfection.
Clin Immunol Immunopathol, 84 (1997), pp. 36-45
[9.]
S. Than, R. Hu, N. Oyaizu, J. Romano, X. Wang, S. Sheikh, et al.
Cytokine pattern in relation to disease progression in human immunodeficiency virus-infected children.
J Infect Dis, 175 (1997), pp. 47-56
[10.]
E. Obregón, C. Börner, J. Navarro, M.D. Gurbindo, E. Fernández-Cruz, M.A. Muñoz-Fernández.
Elevated leels of circulating intercellular adhesion molecule 1 and tumor necrosis factor a in the serum of children vertically infection with HIV-1. Pediatric AIDS and HIV Infection.
Fetus and adolescent, 7 (1996), pp. 413-417
[11.]
C.C. Brown, G. Poli, N. Lubaki, M. St. Louis, F. Davachi, L. Musey, et al.
Elevated levels of tumor necrosis factor-alpha in Zairian neonate plasmas: implications for perinatal infection with the human immunodeficiency virus.
J Infect Dis, 169 (1994), pp. 975-980
[12.]
E.J. Duh, W.J. Maury, T.M. Folks, A.S. Fauci, A.B. Rabson.
Tumor necrosis factor alpha activates human immunodeficiency virus type 1 throughinduction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.
Am J Obstet Gynecol, 161 (1989), pp. 501-502
[13.]
M.A. Muñoz-Fernández, J. Navarro, A. García, C. Punzón, E. Fernández-Cruz, M. Fresno.
Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation.
J Allergy Clin Immunol, 100 (1997), pp. 838-845
[14.]
A. Vyakarman, J. McKeating, A. Meager, P.C. Beverley.
Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication.
Aids, 4 (1990), pp. 21-27
[15.]
M.P. Bevilacqua.
Endothelial-leukocyte adhesion molecules.
Annu Rev Immunol, 11 (1993), pp. 767-804
[16.]
C.A. Dinarello.
Biologic basis for interleukin-1 in disease.
Blood, 87 (1996), pp. 2096-2147
[17.]
F. Puppo, S. Brenci, M. Scudeletti, L. Lanza, O. Bosco, F. Indiveri.
Elevated serum levels of circulating intercellular adhesion molecule-1 in HIV infection.
Aids, 7 (1993), pp. 593-594
[18.]
J. Most, R. Zangerle, M. Herold, D. Fuchs, H. Wachter, P. Fritsch, et al.
Elevated concentrations of circulating intercellular adhesion molecule 1 (ICAM-1) inHIV-1 infection.
J Acquir Immune Defic Syndr, 6 (1993), pp. 221-226
[19.]
M. Tsujisaki, K. Imai, H. Hirata, Y. Hanzawa, J. Masuya, T. Nakano, et al.
Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases.
Clin Exp Immunol, 85 (1991), pp. 3-8
[20.]
M.A. Muñoz-Fernández, E. Obregón, J. Navarro, C. Borner, M.D. Gurbindo, T.H. Sampelayo.
Relationship of virologic, immunologic and clinical parameters in infants with vertically acquired humanimmunodeficiency virus type 1 infection.
Pediatr Res, 40 (1996), pp. 597-602
[21.]
CDCP..
Center for Diseases Control Prevention. Revised classification systemfor HIV-1 infection in children less than 13 years of age.
Mmwr, 43 (1994), pp. 1-13
[22.]
S. Resino, J.L. Jiménez, D. Gurbindo, M.A. Muñoz-Fernández.
Marcadores predictivos de supervivencia en niños menores de 12 meses de edad infectados verticalmente por el virus de la inmunodeficiencia humana.
Med Clin (Barc), 113 (1999), pp. 561-566
[23.]
G. Poli, A. Kinter, J.S. Justement, J.H. Kehrl, P. Bressler, S. Stanley, et al.
Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression.
Proc Natl Acad Sci USA, 87 (1990), pp. 782-795
[24.]
G. Herbein, S. Keshav, M. Collin, L.J. Montaner, S. Gordon.
HIV-1 induces tumour necrosis factor and IL-1 gene expression in-primary human macrophages independent of productive infection.
Clin Exp Immunol, 95 (1994), pp. 442-449
[25.]
K. Hestdal, P. Aukrust, F. Muller, E. Lien, V. Bjerkeli, T. Espevik, et al.
Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load.
Pediatr Infec Dis J, 16 (1997), pp. 963-967
[26.]
L. Monno, G.B. Zimatore, M. Di Stefano, A. Appice, P. Livrea, G. Angarano.
Reduced concentrations of HIV-RNA and TNF-alpha coexist in CSF of AIDS patients with progressive multifocal leukoencephalopathy.
J Neurol Neurosurg Psychiatry, 67 (1999), pp. 369-373
[27.]
L.M. Mofenson, J. Korelitz, W.A. Meyer 3rd, J. Bethel, K. Rich, S. Pahwa, et al.
The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development IntravenousImmunoglobulinClinical Trial Study Group.
J Infect Dis, 175 (1997), pp. 1029-1038
[28.]
S. Resino, M.D. Gurbindo, J.M. Bellón, S. Sánchez-Ramón, M.A. Muñoz-Fernández.
Predictive markers of clinical outcome in vertically HIV-1 infected infants, a prospective longitudinal study.
Pediatr Res, 47 (2000), pp. 1-7
[29.]
G. Poli, A. Fauci.
Role of cytokines in the pathogenesis of human immunodeficiency virus infection.
Human cytokines: their role in disease and therapy, pp. 421-449
[30.]
T. Matsuyama, N. Kobayashi, N. Yamamoto.
Cytokines and HIV infection: is Aids a tumor necrosis factor disease?.
Aids, 5 (1991), pp. 1405-1417
[31.]
Resino S, Muñoz-Fernández MA. Marcadores predictivos de evolución de la infección pediátrica por el virus de la inmunodeficiencia humana tipo 1. Acta Pediatr Esp 2000 (en prensa).
[32.]
M. Feldmann, M.J. Elliott, J.N. Woody, R.N. Maini.
Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
Adv Immunol, 64 (1997), pp. 283-350
[33.]
D.M. Meyer, M.L. Dustin, C.P. Carron.
Characterization of intercellular adhesion molecule-1 ectodomain (sICAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1.
J Immunol, 155 (1995), pp. 3578-3584
Copyright © 2000. Asociación Española de Pediatría
Idiomas
Anales de Pediatría
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?